Nicotine Science and Policy

The EU tobacco consultation has exposed a deeper disagreement about the purpose of nicotine policy. One side treats all nicotine use as the problem; the other asks how to reduce the far greater harms caused by smoking. That divide matters because regulation built around abstinence alone can leave adult smokers with fewer credible alternatives to cigarettes. Europe needs a framework that recognises risk differences, protects young people and allows harm reduction to contribute to lower smoking rates.

Brazil’s vaping debate shows how quickly misinformation can become a policy machine. Repeated claims about risk, youth use and regulation shape public understanding long before evidence is given proper context. That matters because smokers may be left believing that legal cigarettes are no more dangerous than smoke-free alternatives. Public health communication should correct confusion, not manufacture it.

Kuwait’s new nicotine rules place vapes and heated tobacco firmly inside the smoking-control framework. That may simplify enforcement, but it also risks flattening important differences between combustible and non-combustible products. Protecting young people and limiting public exposure are legitimate goals, yet regulation should still preserve a clear pathway for adult smokers to move away from cigarettes. Policy becomes stronger when control is matched with a credible understanding of relative risk.

Age-of-sale laws are only as strong as their enforcement. Raising legal thresholds may signal action, but youth protection depends on retailers being checked, illegal sellers being challenged and adults still having credible routes away from smoking. A balanced approach should keep underage users out of nicotine markets without making lower-risk products harder for adult smokers to access. The aim should be targeted control, not broad restriction disguised as protection.

A JAMA publication should raise the standard of the nicotine debate, not narrow it into alarm. Research on smoking, vaping or smoke-free products needs to be read through the lens of comparison: what happens to people who continue smoking, switch completely, or use products alongside cigarettes. The public health value lies in that distinction. Evidence should clarify the movement away from combustion, not be used to make every nicotine product appear equally harmful.